Physician profile
Michael Bradley Markowitz
NPI 1225088032
$464.13
in general payments reported to CMS, 2019-2025
7 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $20.41 · 2023: $92.87 · 2024: $42.64 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $142.97 | 2020-2021 | |
| Biotronik Nro, INC. | $92.87 | 2023 | Biotronik |
| Novo Nordisk INC | $70.10 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $64.08 | 2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $56.26 | 2020-2025 | Airsupra |
| Lilly USA, LLC | $24.19 | 2025 | Zepbound |
| Corcept Therapeutics | $13.66 | 2024 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Markowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.